E
Enwei Pharmaceutical Co Ltd
SZSE:301331
Enwei Pharmaceutical Co Ltd
SZSE:301331
Price:
27.87
CNY
-1.1%
Market Closed
Market Cap:
¥791.3m
Cash Flow Statement
Cash Flow Statement
Enwei Pharmaceutical Co Ltd
Enwei Pharmaceutical Co Ltd
Currency: CNY
| Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
(67)
|
(66)
|
(59)
|
(86)
|
(80)
|
(85)
|
(82)
|
(103)
|
(80)
|
(81)
|
(75)
|
(71)
|
(77)
|
|
| Change in Working Capital |
(258)
|
(259)
|
(268)
|
(341)
|
(303)
|
(290)
|
(294)
|
(375)
|
(295)
|
(311)
|
(321)
|
(328)
|
(341)
|
|
| Cash from Operating Activities |
46
N/A
|
67
+45%
|
62
-7%
|
63
+1%
|
70
+11%
|
84
+20%
|
90
+7%
|
174
+94%
|
105
-39%
|
79
-25%
|
98
+24%
|
64
-35%
|
84
+31%
|
|
| Investing Cash Flow | ||||||||||||||
| Capital Expenditures |
(36)
|
(34)
|
(24)
|
(29)
|
(23)
|
(134)
|
(150)
|
(158)
|
(165)
|
(50)
|
(46)
|
(55)
|
(51)
|
|
| Other Items |
0
|
0
|
(220)
|
(193)
|
(160)
|
90
|
71
|
123
|
62
|
(60)
|
(71)
|
(125)
|
(126)
|
|
| Cash from Investing Activities |
(36)
N/A
|
(33)
+7%
|
(244)
-631%
|
(222)
+9%
|
(183)
+18%
|
(44)
+76%
|
(79)
-79%
|
(35)
+55%
|
(103)
-190%
|
(111)
-7%
|
(118)
-6%
|
(180)
-53%
|
(177)
+2%
|
|
| Financing Cash Flow | ||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
471
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
33
|
220
|
200
|
195
|
0
|
(31)
|
(11)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
(112)
|
(112)
|
(112)
|
(167)
|
(56)
|
(57)
|
(58)
|
(22)
|
(21)
|
|
| Other |
(3)
|
458
|
(12)
|
0
|
(0)
|
(33)
|
(74)
|
(101)
|
(105)
|
(71)
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
(3)
N/A
|
458
N/A
|
458
+0%
|
0
N/A
|
(112)
N/A
|
(145)
-29%
|
(153)
-6%
|
(49)
+68%
|
39
N/A
|
85
+120%
|
92
+9%
|
(37)
N/A
|
(13)
+65%
|
|
| Change in Cash | ||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
8
N/A
|
491
+6 218%
|
277
-44%
|
300
+8%
|
(225)
N/A
|
(105)
+53%
|
(143)
-36%
|
90
N/A
|
41
-54%
|
53
+30%
|
72
+36%
|
(153)
N/A
|
(106)
+31%
|
|
| Free Cash Flow | ||||||||||||||
| Free Cash Flow |
10
N/A
|
33
+224%
|
39
+17%
|
34
-12%
|
47
+39%
|
(50)
N/A
|
(61)
-21%
|
15
N/A
|
(59)
N/A
|
29
N/A
|
51
+79%
|
9
-82%
|
33
+263%
|
|
Switch to:
Switch to:
See Also
Discover More
